Courtney Beers
Director/Board Member at SANGAMO THERAPEUTICS, INC.
Net worth: 32 515 $ as of 30/05/2024
Profile
Courtney Beers is currently the Director at Sangamo Therapeutics, Inc. since 2022 and the Chief Scientific Officer at Tizona Therapeutics, Inc. since 2019.
Previously, Dr. Beers worked at Cascadian Therapeutics LLC as the Head-Cancer Immunotherapy.
Dr. Beers holds a doctorate degree from the University of Washington.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 03/06/2024 | 57,650 ( 0.03% ) | 32 515 $ | 30/05/2024 |
Courtney Beers active positions
| Companies | Position | Start |
|---|---|---|
| SANGAMO THERAPEUTICS, INC. | Director/Board Member | 14/12/2022 |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | 31/12/2018 |
Former positions of Courtney Beers
| Companies | Position | End |
|---|---|---|
| CASCADIAN THERAPEUTICS INC (USA) | Corporate Officer/Principal | - |
Training of Courtney Beers
| University of Washington | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew M. Pardoll, Dario Vignali, Wayne A. Marasco and Jedd D. Wolchok and is headquartered in South San Francisco, CA. | Health Technology |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Cascadian Therapeutics LLC was a clinical-stage biopharmaceutical company, which focused on the development of therapeutic products for the treatment of cancer. Its product ONT-380, was an orally active and selective small-molecule HER2 inhibitor. The firm also developed preclinical product candidates in oncology using Chk1 kinase inhibitor and protocell technology. The company was founded on August 23, 1985 and was headquartered in Bothell, WA. | Health Technology |
- Stock Market
- Insiders
- Courtney Beers
